News
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.
1d
Zacks Investment Research on MSNHere's How Lilly's Non-Obesity Drugs are Contributing to Sales GrowthWhile Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...
A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...
3don MSN
A new study from US scientists has predicted a huge increase in this killer cancer-and there's one group in particular at ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...
(Reuters) -Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.
By 2030, experts estimate that approximately 50% of Americans will be living with obesity. 4 In 2021, over two-thirds of Medicare beneficiaries were affected by obesity. 5 Additionally, obesity costs ...
People with obesity have a higher risk of developing 13 cancers, and the new research found a reduced risk for 10 of these cancers in patients with type 2 diabetes who were prescribed a GLP-1 ...
Since 1975, the number of people with obesity around the world has almost tripled. According to the World Health Organization, this sharp increase is a major health concern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results